CWA Asset Management Group’s Ironwood Pharmaceuticals IRWD Stock Holding History

CWA Asset Management Group’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.22M	Buy	+290,366	New	+$1.12M	0.04%	367

Other funds holding IRWD

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return

NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return

Range Financial Group Tigard, Oregon $366M AUM 76.17% 1-Year Est. Return

True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return

Dogwood Wealth Management Lenexa, Kansas $253M AUM 19.41% 1-Year Est. Return

Ritter Daniher Financial Advisory Cincinnati, Ohio $657M AUM 20.27% 1-Year Est. Return

CWA Asset Management Group's IRWD Position: Q2 2026 in Review

CWA Asset Management Group opened a new position in Ironwood Pharmaceuticals (IRWD) in Q2 2026: 290,366 shares worth $1.22M. The stake represents 0.04% of the portfolio and ranks #367 among its holdings.

11 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

CWA Asset Management Group held 290,366 shares of Ironwood Pharmaceuticals worth $1.22M as of Q2 2026.
Ironwood Pharmaceuticals was a new CWA Asset Management Group position in Q2 2026.
Ironwood Pharmaceuticals made up 0.04% of CWA Asset Management Group's portfolio in Q2 2026, its #367 holding.
11 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on CWA Asset Management Group's 13F filing for Q2 2026, filed 14 Jul 2026.